Bifidobacterium infantis 35624 efficacy in patients with uncontrolled asthma: A randomized placebo-controlled trial.

Sasipa Sangkanjanavanich, Panitan Pradubpongsa, Wat Mitthamsiri, Atik Sangasapaviliya, Tadech Boonpiyathad

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2022;129(6):790-792

PMID: 36089255

Full Text on Elsevier Science View on PubMed

Abstract

Address: Division of Allergy and Clinical Immunology, Department of Medicine Phramongkutklao Hospital, Bangkok, Thailand; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.; Division of Allergy and Clinical Immunology, Department of Medicine Phramongkutklao Hospital, Bangkok, Thailand.; Division of Allergy and Clinical Immunology, Department of Medicine Phramongkutklao Hospital, Bangkok, Thailand. Electronic address: [email protected].

DOI: 10.1016/j.anai.2022.08.1000

Link outs

Free resources

Medical:

https://medlineplus.gov/asthma.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Humans, Bifidobacterium longum subspecies infantis, Bifidobacterium, Probiotics, Asthma, Double-Blind Method